Skip to content

Analgesic Effect of Peripheral Cutaneous Nerve Block of Knee Joint After Total Knee Arthroplasty

Analgesic Effect of Peripheral Cutaneous Nerve Block of Knee Joint After Total Knee Arthroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05202730
Enrollment
120
Registered
2022-01-21
Start date
2021-12-25
Completion date
2023-12-10
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Arthroplasty, Replacement, Knee

Brief summary

Local anesthesia was performed on patients with total knee arthroplasty (TKA) through two different injection sites of local anesthetics and two local anesthetic drug . The pain score of patients after TKA was collected, then the analgesic effect of patients after TKA through two different injection sites and two different local anesthetic drug were analyzed and evaluated.

Interventions

PROCEDURENew local anesthesia injection site and new local anesthetic drug formulation.

The traditional injection site is the posterior joint capsule and the popliteal artery space (iPACK) plus multiple layers of tissues around the knee joint (posterior joint capsule, ligaments and subcutaneous tissue). The traditional local anesthetic formulation is 1% ropivacaine 10ml+ normal saline 40ml+10mg Morphine + 5mg dexamethasone. The new local anesthesia injection site is iPACK+Knee Cutaneous Nerve Block. The new local anesthetic formula is 1% ropivacaine 10ml+ normal saline 40ml+10mg morphine+1ml triamcinolone acetonide.

Sponsors

Diwuweilong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Patients between the ages of 40-75, who meet the indications for total knee arthroplasty(TKA) surgery, plan to undergo unilateral TKA surgery, can tolerate surgical trauma, and have no surgical contraindications; * 2\. Patients who have good medical obedience and can cooperate to complete the evaluation of various indicators after the operation and continue to receive follow-up; * 3\. There is no contraindications to combined spinal-epidural anesthesia; * 4\. Agree to accept this trial and sign an informed consent form.

Exclusion criteria

* 1\. Allergic to test drugs; * 2\. Abnormal liver, kidney or heart function; * 3\. People who have chronic pain symptoms in other parts of the body other than the knee joint; * 4\. Patients with a history of multiple operations on the knee joint, or patients with abnormal anatomical structures; * 5\. Patients who cannot perform early functional exercise after unconventional knee replacement or other systemic diseases; * 6\. Cannot communicate with researchers normally.

Design outcomes

Primary

MeasureTime frameDescription
Change of the pain score before and after surgerypre-operation, 6hours after surgery, 24hours after surgery, 48 hours after surgery.A Visual Analogue Scale (VAS) is used to measure the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain. Using a ruler, the score is determined by measuring the distance (mm) on the 10cm line between the no pain anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

Countries

China

Contacts

Primary ContactWeilong Diwu, M.M.
diwuweilong@sohu.com+8618792498312

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026